Form D — FibroBiologics, Inc.
0001493152-25-028000 · filed Dec 16, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,725,001
- Reported amount sold
- $1,725,001
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- FibroBiologics, Inc.
- CIK
- 1958777
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 9350 KIRBY DRIVE
HOUSTON, Texas 77054 - Phone
- 281-671-5150
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Pete O'Heeron · Executive OfficerHouston, Texas Find on LinkedIn ↗
-
Stacy Coen · DirectorHouston, Texas Find on LinkedIn ↗
-
Robert Hoffman · DirectorHouston, Texas Find on LinkedIn ↗
-
Matthew Link · DirectorHouston, Texas Find on LinkedIn ↗
-
Victoria Niklas · DirectorHouston, Texas Find on LinkedIn ↗
-
Richard C. Cilento · DirectorHouston, Texas Find on LinkedIn ↗
-
Jason D. Davis · Executive OfficerHouston, Texas Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗